Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 2
2009 1
2010 1
2011 1
2014 1
2015 2
2016 2
2017 4
2018 5
2019 1
2020 3
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

22 results
Results by year
Filters applied: . Clear all
Page 1
Low PD-1 Expression in Cytotoxic CD8+ Tumor-Infiltrating Lymphocytes Confers an Immune-Privileged Tissue Microenvironment in NSCLC with a Prognostic and Predictive Value.
Mazzaschi G, Madeddu D, Falco A, Bocchialini G, Goldoni M, Sogni F, Armani G, Lagrasta CA, Lorusso B, Mangiaracina C, Vilella R, Frati C, Alfieri R, Ampollini L, Veneziani M, Silini EM, Ardizzoni A, Urbanek K, Aversa F, Quaini F, Tiseo M. Mazzaschi G, et al. Among authors: lagrasta ca. Clin Cancer Res. 2018 Jan 15;24(2):407-419. doi: 10.1158/1078-0432.CCR-17-2156. Epub 2017 Oct 26. Clin Cancer Res. 2018. PMID: 29074606 Free article.
Third generation EGFR inhibitor osimertinib combined with pemetrexed or cisplatin exerts long-lasting anti-tumor effect in EGFR-mutated pre-clinical models of NSCLC.
La Monica S, Minari R, Cretella D, Flammini L, Fumarola C, Bonelli M, Cavazzoni A, Digiacomo G, Galetti M, Madeddu D, Falco A, Lagrasta CA, Squadrilli A, Barocelli E, Romanel A, Quaini F, Petronini PG, Tiseo M, Alfieri R. La Monica S, et al. Among authors: lagrasta ca. J Exp Clin Cancer Res. 2019 May 28;38(1):222. doi: 10.1186/s13046-019-1240-x. J Exp Clin Cancer Res. 2019. PMID: 31138260 Free PMC article.
Cardioprotection by Targeting the Pool of Resident and Extracardiac Progenitors.
Urbanek K, Frati C, Graiani G, Madeddu D, Falco A, Cavalli S, Lorusso B, Gervasi A, Prezioso L, Savi M, Ferraro F, Galaverna F, Rossetti P, Lagrasta CA, Re F, Quaini E, Rossi F, Angelis AD, Quaini F. Urbanek K, et al. Among authors: lagrasta ca. Curr Drug Targets. 2015;16(8):884-94. doi: 10.2174/1389450116666150126105002. Curr Drug Targets. 2015. PMID: 25619752 Review.
Imatinib mesylate-induced cardiomyopathy involves resident cardiac progenitors.
Savi M, Frati C, Cavalli S, Graiani G, Galati S, Buschini A, Madeddu D, Falco A, Prezioso L, Mazzaschi G, Galaverna F, Lagrasta CAM, Corradini E, De Angelis A, Cappetta D, Berrino L, Aversa F, Quaini F, Urbanek K. Savi M, et al. Among authors: lagrasta cam. Pharmacol Res. 2018 Jan;127:15-25. doi: 10.1016/j.phrs.2017.09.020. Epub 2017 Sep 28. Pharmacol Res. 2018. PMID: 28964914
Emergence of a HER2-amplified clone during disease progression in an ALK-rearranged NSCLC patient treated with ALK-inhibitors: a case report.
Minari R, Gnetti L, Lagrasta CA, Squadrilli A, Bordi P, Azzoni C, Bottarelli L, Cosenza A, Ferri L, Caruso G, Silini EM, Tiseo M. Minari R, et al. Among authors: lagrasta ca. Transl Lung Cancer Res. 2020 Jun;9(3):787-792. doi: 10.21037/tlcr.2020.04.03. Transl Lung Cancer Res. 2020. PMID: 32676339 Free PMC article.
Blood and lymphatic vessels contribute to the impact of the immune microenvironment on clinical outcome in non-small-cell lung cancer.
Armani G, Madeddu D, Mazzaschi G, Bocchialini G, Sogni F, Frati C, Lorusso B, Falco A, Lagrasta CA, Cavalli S, Mangiaracina C, Vilella R, Becchi G, Gnetti L, Corradini E, Quaini E, Urbanek K, Goldoni M, Carbognani P, Ampollini L, Quaini F. Armani G, et al. Among authors: lagrasta ca. Eur J Cardiothorac Surg. 2018 Jun 1;53(6):1205-1213. doi: 10.1093/ejcts/ezx492. Eur J Cardiothorac Surg. 2018. PMID: 29346540
22 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page